BR112013005305A2 - sistemas terapêuticos transdérmicos com filme protetor inibidor de cristalização (revestimento de liberação) - Google Patents

sistemas terapêuticos transdérmicos com filme protetor inibidor de cristalização (revestimento de liberação)

Info

Publication number
BR112013005305A2
BR112013005305A2 BR112013005305A BR112013005305A BR112013005305A2 BR 112013005305 A2 BR112013005305 A2 BR 112013005305A2 BR 112013005305 A BR112013005305 A BR 112013005305A BR 112013005305 A BR112013005305 A BR 112013005305A BR 112013005305 A2 BR112013005305 A2 BR 112013005305A2
Authority
BR
Brazil
Prior art keywords
protective film
release coating
transdermal therapeutic
crystallization inhibitor
therapeutic systems
Prior art date
Application number
BR112013005305A
Other languages
English (en)
Portuguese (pt)
Inventor
Ildiko Terebesi
Stefan Bracht
Thomas Langguth
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44653285&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112013005305(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of BR112013005305A2 publication Critical patent/BR112013005305A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112013005305A 2010-09-06 2011-09-02 sistemas terapêuticos transdérmicos com filme protetor inibidor de cristalização (revestimento de liberação) BR112013005305A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102010040299A DE102010040299A1 (de) 2010-09-06 2010-09-06 Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
PCT/EP2011/065204 WO2012031985A1 (de) 2010-09-06 2011-09-02 Transdermale therapeutische systeme mit kristallisationsinhibierender schutzfolie (release liner)

Publications (1)

Publication Number Publication Date
BR112013005305A2 true BR112013005305A2 (pt) 2016-08-16

Family

ID=44653285

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013005305A BR112013005305A2 (pt) 2010-09-06 2011-09-02 sistemas terapêuticos transdérmicos com filme protetor inibidor de cristalização (revestimento de liberação)

Country Status (33)

Country Link
US (2) US8557279B2 (enExample)
EP (1) EP2613771A1 (enExample)
JP (2) JP6104800B2 (enExample)
KR (1) KR20130114127A (enExample)
CN (1) CN103079549B (enExample)
AP (1) AP3586A (enExample)
AR (1) AR082907A1 (enExample)
AU (1) AU2011298892B2 (enExample)
BR (1) BR112013005305A2 (enExample)
CA (1) CA2810103C (enExample)
CL (1) CL2013000636A1 (enExample)
CO (1) CO6690753A2 (enExample)
CR (1) CR20130098A (enExample)
CU (1) CU24172B1 (enExample)
DE (1) DE102010040299A1 (enExample)
DO (1) DOP2013000053A (enExample)
EA (1) EA032575B1 (enExample)
EC (1) ECSP13012477A (enExample)
GT (1) GT201300062A (enExample)
IL (2) IL224980A (enExample)
MA (1) MA34581B1 (enExample)
MX (1) MX2013002602A (enExample)
MY (1) MY162768A (enExample)
NZ (1) NZ607630A (enExample)
PE (2) PE20131138A1 (enExample)
PH (1) PH12013500429A1 (enExample)
SG (2) SG187941A1 (enExample)
TN (1) TN2013000087A1 (enExample)
TW (1) TWI576245B (enExample)
UA (1) UA110217C2 (enExample)
UY (1) UY33590A (enExample)
WO (1) WO2012031985A1 (enExample)
ZA (1) ZA201301389B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI541246B (zh) 2008-12-08 2016-07-11 歐陸斯迪公司 二氫羥戊甲嗎啡
GB201309654D0 (en) 2013-05-30 2013-07-17 Euro Celtique Sa Method

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH674618A5 (enExample) * 1987-04-02 1990-06-29 Ciba Geigy Ag
DE58909570D1 (de) * 1988-10-27 1996-02-22 Schering Ag Mittel zur transdermalen applikation enthaltend gestoden
WO1992007590A1 (en) 1990-10-29 1992-05-14 Alza Corporation Transdermal contraceptive formulations, methods and devices
US5512292A (en) 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
DE4210711A1 (de) 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
DE4336557C2 (de) 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4405898A1 (de) 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
DE4405899A1 (de) * 1994-02-18 1995-08-24 Schering Ag Mittel zur transdermalen Applikation enthaltend Desogestrel
US5762956A (en) 1996-04-24 1998-06-09 Rutgers, The State University Of New Jersey Transdermal contraceptive delivery system and process
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
DE19906152B4 (de) 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
WO2001037770A1 (en) 1999-11-24 2001-05-31 Agile Therapeutics, Inc. Improved transdermal contraceptive delivery system and process
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
TWI287455B (en) 2000-12-05 2007-10-01 Noven Pharma Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use
EP1216699A1 (de) 2000-12-21 2002-06-26 Schering Aktiengesellschaft Transdermalsystem enthaltend ein hochpotentes Gestagen
US20030165547A1 (en) * 2001-05-18 2003-09-04 Elisabeth Picard-Lesboueyries Cosmetic uses of 3beta-acetoxy-7-oxo-DHEA
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
HRP20050828B1 (hr) * 2003-02-21 2013-10-25 Bayer Intellectual Property Gmbh Uv-stabilni transdermalni flaster
US8668925B2 (en) * 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
NZ548091A (en) * 2003-12-12 2009-12-24 Bayer Schering Pharma Ag Transdermal delivery system of hormones without penetration enhancers
UA89766C2 (en) * 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene
ES2596809T3 (es) * 2004-10-08 2017-01-12 Noven Pharmaceuticals, Inc. Dispositivo de administración transdérmica de fármacos que incluye un refuerzo oclusivo
DE102004062182B4 (de) 2004-12-20 2007-06-06 Bayer Schering Pharma Ag Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff
US8962013B2 (en) * 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
DE102005050729A1 (de) 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
CN102281873A (zh) * 2008-10-06 2011-12-14 迈兰技术有限公司 非晶罗替戈汀(rotigotine)透皮系统

Also Published As

Publication number Publication date
MX2013002602A (es) 2013-04-08
TN2013000087A1 (en) 2014-06-25
CU24172B1 (es) 2016-04-25
IL251124B (en) 2020-07-30
AP3586A (en) 2016-02-10
CA2810103C (en) 2019-06-18
PH12013500429A1 (en) 2019-10-07
IL251124A0 (en) 2017-04-30
EP2613771A1 (de) 2013-07-17
JP2016216500A (ja) 2016-12-22
CR20130098A (es) 2013-05-15
CN103079549B (zh) 2016-11-02
AU2011298892B2 (en) 2015-03-12
US8557279B2 (en) 2013-10-15
US20140018751A1 (en) 2014-01-16
PE20131138A1 (es) 2013-10-26
DE102010040299A1 (de) 2012-03-08
PE20180198A1 (es) 2018-01-26
SG10201506927TA (en) 2015-10-29
CL2013000636A1 (es) 2013-09-13
TWI576245B (zh) 2017-04-01
EA032575B1 (ru) 2019-06-28
JP2013536828A (ja) 2013-09-26
KR20130114127A (ko) 2013-10-16
TW201217165A (en) 2012-05-01
UA110217C2 (en) 2015-12-10
ZA201301389B (en) 2021-05-26
AP2013006787A0 (en) 2013-04-30
SG187941A1 (en) 2013-04-30
IL224980A (en) 2017-07-31
CN103079549A (zh) 2013-05-01
US9060955B2 (en) 2015-06-23
US20120082714A1 (en) 2012-04-05
NZ607630A (en) 2015-02-27
JP6104800B2 (ja) 2017-03-29
CU20130031A7 (es) 2013-05-31
MY162768A (en) 2017-07-14
AU2011298892A1 (en) 2013-03-28
UY33590A (es) 2011-10-31
AR082907A1 (es) 2013-01-16
ECSP13012477A (es) 2013-04-30
EA201390246A1 (ru) 2013-09-30
CO6690753A2 (es) 2013-06-17
MA34581B1 (fr) 2013-10-02
WO2012031985A1 (de) 2012-03-15
GT201300062A (es) 2015-01-16
CA2810103A1 (en) 2012-03-15
DOP2013000053A (es) 2013-07-15

Similar Documents

Publication Publication Date Title
BR112012032001A2 (pt) filme aderente estirável de face única contendo três camadas
EP2554376A4 (en) SURFACE PROTECTION FILM
BR112014007522A2 (pt) "composição de revestimento conformável e filme conformável"
EP2341875A4 (en) NASAL THIN FILM DILATOR WITH ADMINISTRATION SYSTEM
EP2781569A4 (en) BONDING FILM
EP2767566A4 (en) BONDING FILM
EP2652167A4 (en) Continuous coating apparatus
EP2559745A4 (en) SURFACE PROTECTION FILM
BR112012024092A2 (pt) filme de rápida dissolução oral
EP2700593A4 (en) cover
EP2808368A4 (en) COATING COMPOSITION AND ANTI-REFLECTION FILM
EP2719636A4 (en) cover
EP2792701A4 (en) COATED FOIL
ITMI20111365A1 (it) Inseguitore di camma
FR2968755B1 (fr) Dispositif de protection balistique deportee
EP2722415A4 (en) COATED WITH A HARD COATED ELEMENT
BR112012017399A2 (pt) filme de marcação
EP2733162A4 (en) Coating Film
EP2727954A4 (en) Coating Film
EP2754485A4 (en) COATING DEVICE
FI9160U1 (fi) Pinnoituslaite
EP2611611A4 (en) PATTERNED PROTECTIVE FOIL
EP2769841A4 (en) Coating Film
BR112013005305A2 (pt) sistemas terapêuticos transdérmicos com filme protetor inibidor de cristalização (revestimento de liberação)
DK2619276T3 (da) Tokomponents pigmenteret beskyttelsesbelægning

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL